2.59 USD
↘ 0.02 (0.77%)AT CLOSE (11:59 AM EDT)
Virax Biolabs Group Limited Ordinary Shares
VRAXNASDAQ • USD
2.63
↗ 0.04 (1.35%)
POST MARKET (AS OF 06:14 PM EDT)
Post Market
AS OF 06:14 PM EDT
2.63
↗ 0.04 (1.35%)
Market: OPEN
VRAX is currently priced at $2.63. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Notable factors include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Sep 15, 2026.
Open?$2.66
High?$2.78
Low?$2.58
Prev. Close?$2.61
Volume?24.4K
Avg. Volume?N/A
VWAP?$2.71
Bid / Ask
Bid?$2.23 × 100
Ask?$3.03 × 100
Spread?$0.80
Midpoint?$2.63
Valuation & Ratios
Market Cap?2.1M
Shares Out?796.9K
Float?7.0M
Float %?94.5%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?0.28%Low
Short Interest?20.0K
Days to Cover?1.0
Free Float7.0M
Avg Daily Volume1.7M
Settlement Date2026-08-31